Scholars@Duke publication: Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.

Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.

Publication , Journal Article

Clowse, MEB; Harward, L; Criscione-Schreiber, L; Pisetsky, D; Copland, S

Published in: Arthritis Rheum

May 2012

Published version (DOI) Link to item

Duke Scholars

Author Megan Elizabeth Bowles Clowse Medicine, Rheumatology and Immunology

Author Lisa Giorgina Criscione-Schreiber Medicine, Rheumatology and Immunology

Author David Stephen Pisetsky Medicine, Rheumatology and Immunology

Altmetric Attention Stats

Dimensions Citation Stats

Published In

Arthritis Rheum

DOI

10.1002/art.34431

EISSN

1529-0131

Publication Date

May 2012

Volume

Issue

Start / End Page

1305 / 1310

Location

United States

Related Subject Headings

Rheumatic Diseases
Primary Ovarian Insufficiency
Ovary
Immunosuppressive Agents
Humans
Follicle Stimulating Hormone
Female
Cyclophosphamide
Biomarkers
Arthritis & Rheumatology

Citation

APA

Chicago

ICMJE

MLA

NLM

Clowse, M. E. B., Harward, L., Criscione-Schreiber, L., Pisetsky, D., & Copland, S. (2012). Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum, 64(5), 1305–1310. https://doi.org/10.1002/art.34431

Clowse, Megan E. B., Lindsey Harward, Lisa Criscione-Schreiber, David Pisetsky, and Susannah Copland. “Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.” Arthritis Rheum 64, no. 5 (May 2012): 1305–10. https://doi.org/10.1002/art.34431.

Clowse MEB, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S. Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum. 2012 May;64(5):1305–10.

Clowse, Megan E. B., et al. “Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.” Arthritis Rheum, vol. 64, no. 5, May 2012, pp. 1305–10. Pubmed, doi:10.1002/art.34431.

Clowse MEB, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S. Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum. 2012 May;64(5):1305–1310.

Published In

Arthritis Rheum

DOI

10.1002/art.34431

EISSN

1529-0131

Publication Date

May 2012

Volume

Issue

Start / End Page

1305 / 1310

Location

United States

Related Subject Headings

Rheumatic Diseases
Primary Ovarian Insufficiency
Ovary
Immunosuppressive Agents
Humans
Follicle Stimulating Hormone
Female
Cyclophosphamide
Biomarkers
Arthritis & Rheumatology